Research center
The Leloir Institute Foundation (FIL) is a center for scientific research dedicated to research and human resources formation through postgraduate teaching in Biochemistry and Cellular and Molecular Biology.
It is a non-profit organization that operates under Argentinian legal regulations. It was established in 1947 under the leadership of Dr. Luis Federico Leloir (Nobel Prize in Chemistry, 1970).
It is closely associated with CONICET (National Scientific and Technical Research Council), the University of Buenos Aires, the University of Quilmes, and the University of San Martin.
Research lines
The research conducted in the laboratories at FIL can be grouped into four major areas: Cellular Biology and Cancer, Neuroscience and Neurodegenerative Diseases, Molecular Microbiology and Vaccine Development, and Genetics and Molecular Biology of Plants of Agronomic Interest.
Furthermore, FIL has made significant progress in recent years in Technology Transfer through the creation of the Inis Biotech company and a biotechnology entrepreneurship incubator.
Instrumentation
- 600 MHz NMR spectrometer with cryoprobe.
- X-ray diffractometer.
- Crystallization robot.
- Controlled-temperature room for crystal growth.
- Biophysical techniques (CD, fluorescence, stopped flow, biosensor, ITC).
- Extensive equipment for protein chemistry, molecular biology, and cell biology.
- State-of-the-art animal facility.
- Confocal microscopy laboratory.
-
- Honeybee963 robot for crystallization screening
-
- Bruker AVANCE III 600 MHz NMR spectrometer equipped with a high-sensitivity cryoprobe
-
- Bruker D8 QUEST diffractometer with microfocus copper source
-
- Controlled-temperature crystallization room for macromolecules
- Av. Patricias Argentinas 435. Ciudad de Bs As. (C1405BWE). Argentina.
- +54-11- 5238-7500
- sklinke@leloir.org.ar
- http://www.leloir.org.ar/
Five days of intense work, hands-on learning and scientific collaboration at @CNPEM 🇧🇷
Researchers from Latin America and Europe came together to explore the intersection between drug discovery and structural biology, through theoretical sessions and practical training.
